Literature DB >> 15957515

Severity of chronic pain and its relationship to quality of life in multiple sclerosis.

Lorraine V Kalia1, Paul W O'Connor.   

Abstract

INTRODUCTION: This study used reliable and validated instruments to compare pain severity in multiple sclerosis (MS) to that in other chronic painful conditions, and to examine relationships between chronic pain in MS and health-related quality of life (HRQOL).
METHODS: Ninety-nine MS patients completed a self-administered survey comprised of the Medical Outcomes 36-Item Short-Form Health Survey, the Short-Form McGill Pain Questionnaire, and the Hospital Anxiety and Depression Scale.
RESULTS: Pain severity was not different between MS patients with pain and rheumatoid arthritis (P = 0.77) or osteoarthritis (P = 0.98) patients. Chronic pain in MS was less often neurogenic than non-neurogenic, although severity of neurogenic pain was greater than that of non-neurogenic pain (P = 0.048). Chronic pain in MS was found to have no significant relationship to age, disease duration or disease course. Instead, we found that pain was correlated with aspects of HRQOL, particularly mental health (r = 0.44, P < 0.0001) versus physical functioning (r = 0.19, P > 0.05). Chronic pain was significantly related to anxiety and depression for females but not for males with MS.
CONCLUSIONS: Chronic pain in MS is as severe as pain in arthritic conditions and is associated with reduced HRQOL. Thus, pain can be a significant symptom for MS patients and the need for treatment may be underestimated.

Entities:  

Mesh:

Year:  2005        PMID: 15957515     DOI: 10.1191/1352458505ms1168oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  51 in total

1.  The effect of CTAB, a cationic surfactant, on the absorption rate of [14C]tripalmitate from a test meal in the rat.

Authors:  B Isomaa; G Sjöblom
Journal:  Food Cosmet Toxicol       Date:  1975-10

2.  Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis.

Authors:  Colin W Campbell; Edward J S Jones; Jane Merrills
Journal:  Clin Med (Lond)       Date:  2010-06       Impact factor: 2.659

3.  Predictors of anxiety in multiple sclerosis.

Authors:  Narineh Hartoonian; Alexandra L Terrill; Meghan L Beier; Aaron P Turner; Melissa A Day; Kevin N Alschuler
Journal:  Rehabil Psychol       Date:  2014-12-15

4.  CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.

Authors:  Xiaoyu Hu; Fang Huang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2017-11-16       Impact factor: 6.167

5.  Systematic assessment and characterization of chronic pain in multiple sclerosis patients.

Authors:  Diana Ferraro; Domenico Plantone; Franca Morselli; Giulia Dallari; Anna M Simone; Francesca Vitetta; Patrizia Sola; Guido Primiano; Viviana Nociti; Matteo Pardini; Massimiliano Mirabella; Catello Vollono
Journal:  Neurol Sci       Date:  2017-12-09       Impact factor: 3.307

6.  The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.

Authors:  Pamela K Newland; Robert T Naismith; Margaret Ullione
Journal:  J Neurosci Nurs       Date:  2009-12       Impact factor: 1.230

Review 7.  Multiple sclerosis-related central pain disorders.

Authors:  Turo J Nurmikko; Sameer Gupta; Kate Maclver
Journal:  Curr Pain Headache Rep       Date:  2010-06

8.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

9.  Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook; Rachael C Gliottoni
Journal:  Psychol Health Med       Date:  2009-01       Impact factor: 2.423

10.  Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.

Authors:  Jessica L Lynch; Jeremy F Alley; Lori Wellman; Alvin J Beitz
Journal:  Brain Res       Date:  2007-11-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.